{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:10:05Z","timestamp":1784265005237,"version":"3.55.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and aims<\/jats:title>\n                  <jats:p>Confocal endomicroscopy is a technique allowing the in vivo assessment of the superficial layers of the mucosa. Preliminary studies have already suggested its added value in the assessment of endoscopic remission in inflammatory bowel disease. However, most of these studies were performed on patients still having incomplete mucosal healing. Our aim was to disclose persisting endomicroscopic anomalies in patients with full endoscopic remission and to compare them between vedolizumab- and anti-tumor necrosis factor\u2013treated patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We screened patients with Crohn\u2019s disease (CD) or ulcerative colitis (UC) treated for more than 6 months with biologic therapy, and being in steroid-free clinical and biological remission. White light endoscopy and probe-based confocal laser endomicroscopy (pCLE) analysis were performed in the ileum, right colon, transverse colon, left colon, and rectum. Full endoscopic remission was defined by a Mayo endoscopic score of 0 in UC and no remaining ulcer or erosion in CD. Patients were prospectively followed up and clinical relapses were recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seventy-two CD and UC patients treated by biologic therapy and in clinical and biological remission were screened. A total of 37 were also in full endoscopic remission and were included in our study; 183 intestinal segments were analyzed. We found residual pCLE anomalies in most of the patients. These anomalies were not significantly associated with any demographic or clinical characteristic including the treatment received, nor were they associated with histological parameters, levels of C-reactive protein or fecal calprotectin. Among the 37 patients, 7 (18.9%) relapsed over a median follow-up of 33.7 months. The risk of relapse was not associated with any clinical, biological, histologic, or pCLE feature at baseline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Despite endoscopic, biological, and even histological remission, we found a high prevalence of endomicroscopic abnormalities, which were not different between anti-tumor necrosis factor\u2013 and vedolizumab-treated patients. The clinical significance of these anomalies remains to be clarified.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izad066","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T15:11:35Z","timestamp":1681312295000},"page":"240-246","source":"Crossref","is-referenced-by-count":8,"title":["In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-7129","authenticated-orcid":false,"given":"Jean-Philippe","family":"Loly","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, CHU Li\u00e8ge , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-7146","authenticated-orcid":false,"given":"Sophie","family":"Vieujean","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, CHU Li\u00e8ge , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Reenaers","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, CHU Li\u00e8ge , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Van Kemseke","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, CHU Li\u00e8ge , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Seidel, ScD","sequence":"additional","affiliation":[{"name":"Department of Statistics, CHU Li\u00e8ge , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Louis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, CHU Li\u00e8ge , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Somja","sequence":"additional","affiliation":[{"name":"Department of Pathology, CHU Li\u00e8ge , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"issue":"2","key":"2024020200265934800_CIT0001","first-page":"99","article-title":"Emerging prognostic markers to determine Crohn\u2019s disease natural history and improve management strategies: a review of recent literature","volume":"6","author":"Lichtenstein","year":"2010","journal-title":"Gastroenterol Hepatol."},{"issue":"19","key":"2024020200265934800_CIT0002","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19 Suppl A","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol J Can Gastroenterol"},{"issue":"6","key":"2024020200265934800_CIT0003","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ibd.21506","article-title":"Development of the Crohn\u2019s disease digestive damage score, the L\u00e9mann score","volume":"17","author":"Pariente","year":"2011","journal-title":"Inflamm Bowel Dis."},{"issue":"9","key":"2024020200265934800_CIT0004","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"2024020200265934800_CIT0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","article-title":"Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalization over 6 years of follow-up","volume":"65","author":"Bryant","year":"2016","journal-title":"Gut."},{"issue":"2","key":"2024020200265934800_CIT0006","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Fr\u00f8slie","year":"2007","journal-title":"Gastroenterology."},{"issue":"5","key":"2024020200265934800_CIT0007","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"issue":"9","key":"2024020200265934800_CIT0008","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","article-title":"Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn\u2019s disease","volume":"15","author":"Schnitzler","year":"2009","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2024020200265934800_CIT0009","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","article-title":"Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn\u2019s disease","volume":"138","author":"Baert","year":"2010","journal-title":"Gastroenterology."},{"issue":"8","key":"2024020200265934800_CIT0010","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2011-300695","article-title":"Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease","volume":"61","author":"Kiesslich","year":"2012","journal-title":"Gut."},{"issue":"3","key":"2024020200265934800_CIT0011","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.giec.2008.03.002","article-title":"Confocal laser endomicroscopy for gastrointestinal diseases","volume":"18","author":"Kiesslich","year":"2008","journal-title":"Gastrointest Endosc Clin N Am."},{"issue":"6","key":"2024020200265934800_CIT0012","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/ecco-jcc\/jjaa255","article-title":"Probe-based confocal laser endomicroscopy for in vivo assessment of histological healing in ulcerative colitis: development and validation of the ENHANCE index","volume":"15","author":"Rahmi","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"12","key":"2024020200265934800_CIT0013","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/ecco-jcc\/jjv131","article-title":"Confocal laser endomicroscopy in inflammatory bowel disease--a systematic review","volume":"9","author":"Rasmussen","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"1","key":"2024020200265934800_CIT0014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gie.2019.02.030","article-title":"Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn\u2019s disease: a pilot study","volume":"90","author":"Auzoux","year":"2019","journal-title":"Gastrointest Endosc."},{"issue":"4","key":"2024020200265934800_CIT0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.crohns.2013.09.005","article-title":"Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: a pilot study","volume":"8","author":"Buda","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"1","key":"2024020200265934800_CIT0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","article-title":"Development and validation of the Nancy histological index for UC","volume":"66","author":"Marchal-Bressenot","year":"2017","journal-title":"Gut."},{"issue":"10","key":"2024020200265934800_CIT0017","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/ecco-jcc\/jjab055","article-title":"Validation of the \u00ab Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] score \u00bb for ulcerative colitis and Crohn\u00b4s disease","volume":"15","author":"Lang-Schwarz","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"12","key":"2024020200265934800_CIT0018","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.humpath.2012.03.008","article-title":"A histopathologic scoring system as a tool for standardized reporting of chronic (ileo)colitis and independent risk assessment for inflammatory bowel disease","volume":"43","author":"Naini","year":"2012","journal-title":"Hum Pathol."},{"issue":"1","key":"2024020200265934800_CIT0019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"Mosli","year":"2017","journal-title":"Gut."},{"key":"2024020200265934800_CIT0020","article-title":"Computer-aided imaging analysis of probe-based confocal laser endomicroscopy with molecular labeling and gene expression identifies markers of response to biological therapy in IBD patients: the Endo-Omics study","author":"Iacucci","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2024020200265934800_CIT0021","first-page":"364","article-title":"Confocal laser endomicroscopy: a novel method for prediction of relapse in Crohn\u2019s disease","volume":"48","author":"Karstensen","year":"2016","journal-title":"Endoscopy."},{"key":"2024020200265934800_CIT0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-230X-14-45","article-title":"Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis","volume":"14","author":"Li","year":"2014","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"2024020200265934800_CIT0023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2022.10.014","article-title":"Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the Prospective ERIca trial","volume":"164","author":"Rath","year":"2023","journal-title":"Gastroenterology."},{"issue":"9","key":"2024020200265934800_CIT0024","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/ecco-jcc\/jjaa056","article-title":"Assessment of endoscopic healing by using advanced technologies reflects histological healing in ulcerative colitis","volume":"14","author":"Iacucci","year":"2020","journal-title":"J Crohns Colitis"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad066\/49865525\/izad066.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/2\/240\/56542121\/izad066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/2\/240\/56542121\/izad066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:27:14Z","timestamp":1706833634000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/2\/240\/7115915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4,12]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad066","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2023,4,12]]}}}